Skip to main content

A Retrospective Study on the Development of Inhibitors after Continuous Infusion of Factor VIII

  • Conference paper
  • 104 Accesses

Abstract

The continuous infusion (CI) of coagulation factor-VIII (FVIII) concentrates has been used since the early 1990s. Compared to the traditional way of factor application by episodic bolus infusions (BI) the CI had several advantages:

Steady level of missing coagulation factor, avoiding of unnecessary high peaks of FVIII, saving of 30% FVIII concentrate and reduction in treatment costs [1]. Reports of the occurrence of an inhibitor after treatment with CI have raised concerns about this method of factor application.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Batorova A, Martinowitz U. Continuous infusion of coagulation factors. Haemophilia 2002; 8: 170–177

    Article  PubMed  CAS  Google Scholar 

  2. Oldenburg J, El-Maarri O, Schwaab R. Inhibitor development in correlation to FVIII genotypes. Haemophilia, 2002; 8(Suppl.2): 23–29

    Article  PubMed  CAS  Google Scholar 

  3. Hermans C, Thyn Ye e T, Perry D, Lee C. Development of inhibitor in hemophilia patients treated with continuous infusion. Haemophilia 2002; 8: 541

    Article  Google Scholar 

  4. Koestenberger M, Raith W, Muntean W. High titre inhibitor after continuous factor VIII administration for surgery in a young infant. Haemophilia 2000; 6: 120

    Article  PubMed  CAS  Google Scholar 

  5. White B, Cotter M, Byrne M, O’Shea E, Smith OP. High responding factor VIII inhibitors in mild hemophilia — is there a link with recent changes in clinical practice? Haemophilia, 2000; 6: 113–115

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Auer, C.v. et al. (2004). A Retrospective Study on the Development of Inhibitors after Continuous Infusion of Factor VIII. In: Scharrer, I., Schramm, W. (eds) 33rd Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18260-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18260-0_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00902-3

  • Online ISBN: 978-3-642-18260-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics